$SRNE I believe the timeline of events that makes the most sense (for success) is a positive readout of CD38 CAR-T data followed by a partnership deal. I don't think we'll see a partnership on their CAR-T program before that data is released. I also hope they don't partner with RTX, and are able to fund that program with PSS lawsuit money. There is a wide range of possibilities for this company, both positive and negative. There are some significant data readouts / potential cash infusions that can bring the market cap higher or lower. Notice I said market cap though, if they keep on diluting at the rate they have been, then the share price will continually face stronger headwinds.